Assenagon Asset Management
MEDP icon

Assenagon Asset Management’s Medpace MEDP Stock Holding History

Assenagon Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Sell
25,772
-90,551
-78% -$41.8M 0.02% 477
2026
Q1 		$55.9M Buy
116,323
+109,051
+1,500% +$55.8M 0.08% 181
2025
Q4 		$4.08M Buy
+7,272
New +$4.13M 0.01% 686
2025
Q1 		– Sell
-21,715
Closed -$7.21M – 1272
2024
Q4 		$7.21M Buy
21,715
+793
+4% +$269K 0.01% 596
2024
Q3 		$6.98M Sell
20,922
-65,576
-76% -$24.9M 0.01% 616
2024
Q2 		$35.6M Sell
86,498
-22,024
-20% -$8.72M 0.08% 191
2024
Q1 		$43.9M Buy
108,522
+23,443
+28% +$8.24M 0.1% 156
2023
Q4 		$26.1M Sell
85,079
-39,861
-32% -$10.8M 0.07% 230
2023
Q3 		$30.3M Buy
+124,940
New +$32M 0.09% 187
2023
Q2 		– Sell
-83,502
Closed -$15.7M – 1405
2023
Q1 		$15.7M Buy
83,502
+77,886
+1,387% +$16.1M 0.06% 289
2022
Q4 		$1.19M Sell
5,616
-2
-0% -$400 ﹤0.01% 997
2022
Q3 		$883K Sell
5,618
-2
-0% -$319 ﹤0.01% 959
2022
Q2 		$841K Sell
5,620
-41,419
-88% -$6M ﹤0.01% 1118
2022
Q1 		$7.7M Sell
47,039
-36,347
-44% -$5.99M 0.02% 434
2021
Q4 		$18.1M Buy
83,386
+9,128
+12% +$1.91M 0.05% 223
2021
Q3 		$14.1M Buy
74,258
+42,962
+137% +$7.84M 0.05% 249
2021
Q2 		$5.53M Buy
31,296
+1,542
+5% +$266K 0.02% 462
2021
Q1 		$4.88M Hold
29,754
– – 0.02% 514
2020
Q4 		$4.14M Sell
29,754
-141,764
-83% -$17.9M 0.02% 388
2020
Q3 		$19.2M Buy
+171,518
New +$19.8M 0.11% 130
2020
Q1 		– Sell
-3,756
Closed -$316K – 920
2019
Q4 		$316K Sell
3,756
-6,947
-65% -$538K ﹤0.01% 697
2019
Q3 		$899K Buy
+10,703
New +$809K 0.01% 573
2019
Q2 		– Sell
-90,793
Closed -$5.35M – 1090
2019
Q1 		$5.35M Buy
+90,793
New +$5.42M 0.05% 295

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Assenagon Asset Management's MEDP Position: Q2 2026 in Review

Assenagon Asset Management reduced its Medpace (MEDP) stake by 78% in Q2 2026, selling an estimated $41.8M and leaving 25,772 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #477.

Assenagon Asset Management first reported a position in MEDP in Q1 2019 and has held it in 23 quarters since. The position peaked at $55.9M in Q1 2026. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Assenagon Asset Management held 25,772 shares of Medpace worth $13.6M as of Q2 2026.
  • Assenagon Asset Management sold 90,551 Medpace shares in Q2 2026, an estimated $41.8M.
  • Medpace made up 0.02% of Assenagon Asset Management's portfolio in Q2 2026, its #477 holding.
  • Assenagon Asset Management first reported a position in Medpace in Q1 2019 and has held it in 23 quarters since.
  • Assenagon Asset Management's Medpace position peaked at $55.9M in Q1 2026.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.